UBS Group’s Aptose Biosciences, Inc. APTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,928
Closed -$13K 9574
2024
Q4
$13K Sell
1,928
-2,521
-57% -$17K ﹤0.01% 6934
2024
Q3
$54.9K Buy
+4,449
New +$54.9K ﹤0.01% 5560
2024
Q1
Sell
-253
Closed -$19.3K 9007
2023
Q4
$19.3K Buy
+253
New +$19.3K ﹤0.01% 5920
2023
Q3
Sell
-1
Closed -$125 8098
2023
Q2
$125 Sell
1
-8
-89% -$1K ﹤0.01% 7389
2023
Q1
$2.64K Buy
+9
New +$2.64K ﹤0.01% 7373
2022
Q4
Hold
0
9467
2022
Q3
Hold
0
10132
2022
Q2
Sell
-3
Closed -$2K 10138
2022
Q1
$2K Sell
3
-76
-96% -$50.7K ﹤0.01% 8696
2021
Q4
$48K Buy
79
+38
+93% +$23.1K ﹤0.01% 5856
2021
Q3
$40K Buy
41
+21
+105% +$20.5K ﹤0.01% 5414
2021
Q2
$30K Buy
20
+16
+400% +$24K ﹤0.01% 5870
2021
Q1
$10K Sell
4
-3
-43% -$7.5K ﹤0.01% 6925
2020
Q4
$14K Buy
+7
New +$14K ﹤0.01% 6220
2020
Q3
Sell
-3
Closed -$8K 7541
2020
Q2
$8K Buy
+3
New +$8K ﹤0.01% 6314
2019
Q4
Sell
-12
Closed -$11K 7275
2019
Q3
$11K Buy
12
+5
+71% +$4.58K ﹤0.01% 6160
2019
Q2
$8K Buy
7
+6
+600% +$6.86K ﹤0.01% 6335
2019
Q1
$1K Sell
1
-24
-96% -$24K ﹤0.01% 6751
2018
Q4
$22K Buy
+25
New +$22K ﹤0.01% 5796
2018
Q3
Sell
-7
Closed -$13K 7247
2018
Q2
$13K Buy
7
+2
+40% +$3.71K ﹤0.01% 6084
2018
Q1
$7K Sell
5
-4
-44% -$5.6K ﹤0.01% 6209
2017
Q4
$10K Buy
9
+4
+80% +$4.44K ﹤0.01% 6068
2017
Q3
$3K Buy
5
+2
+67% +$1.2K ﹤0.01% 6491
2017
Q2
$1K Hold
3
﹤0.01% 6584
2017
Q1
$2K Hold
3
﹤0.01% 6387
2016
Q4
$2K Hold
3
﹤0.01% 6542
2016
Q3
$3K Buy
+3
New +$3K ﹤0.01% 6379
2016
Q2
Sell
-6
Closed -$8K 6973
2016
Q1
$8K Buy
6
+5
+500% +$6.67K ﹤0.01% 5950
2015
Q4
$1K Buy
+1
New +$1K ﹤0.01% 6740
2015
Q1
Sell
-8
Closed -$23K 6852
2014
Q4
$23K Buy
+8
New +$23K ﹤0.01% 5397